Alco Holdings Limited Announces Major 2026 Rights Issue: Key Details and Shareholder Implications
Date: 29 May 2026
Key Points of the Report
- Massive Rights Issue Announced: Alco Holdings Limited (HKEX: 328) proposes a significant rights issue for 2026, offering existing shareholders the right to subscribe to four (4) new shares for every one (1) share held at the record date.
- Non-Underwritten Basis: The rights issue will proceed on a non-underwritten basis, meaning there is no guarantee that all rights shares will be subscribed or that all capital will be raised. Any unsubscribed shares will be placed on a best-effort basis by the Placing Agent to independent third parties.
- Subscription Price: The rights shares will be offered at HK\$0.55 per share, representing a 20.3% discount to the last trading price of HK\$0.69 and a 24.2% discount to the 5-day average closing price of HK\$0.726.
- Potential Dilution: If fully subscribed, the rights issue will result in the issuance of up to 229,113,720 new shares, increasing the total issued shares to 286,392,150—an 400% increase over existing shares. Failure to participate will result in substantial dilution for existing shareholders.
- Maximum Fundraising: If fully taken up, the company may raise up to approximately HK\$126 million (before expenses).
- Use of Proceeds: Net proceeds of approximately HK\$121.8 million (after estimated expenses of HK\$4.19 million) will be allocated as follows:
- 41% (HK\$50M) for repayment of high-interest borrowing from Proyan Consultancy Limited (20% p.a. interest rate).
- 18% (HK\$22M) for supplier settlements and trade payables, to normalise supplier cycles and support ongoing business.
- 26% (HK\$31.5M) to develop the Asia-Pacific markets and enhance product design, including new physical stores and 3D printing equipment.
- 15% (HK\$18.3M) for general working capital, including staff, commissions, logistics, rent, compliance, IT, and contingency buffer.
- Key Dates:
- Shares traded ex-rights: 19 May 2026
- Nil-paid rights trading: 2 June to 9 June 2026
- Latest time for acceptance/payment: 4:00 p.m., 12 June 2026
- Placing of unsubscribed shares: 23 June to 3 July 2026
- Listing of new shares: Expected by 13 July 2026
- No Excess Applications: There will be no excess application arrangement; only the provisionally allotted rights can be subscribed.
- Scale-Down Mechanism: If full take-up would trigger a general offer obligation or reduce public float below 25%, applications will be scaled down accordingly.
- Compensatory Arrangements: Unsubscribed rights and those of ineligible overseas shareholders will be placed to independent third parties, with any premium over the subscription price returned (net of expenses) to non-participating shareholders, subject to a HK\$100 minimum.
- Public Float Safeguard: The company assures that, even in the worst-case scenario, the public float will be maintained at or above the 25% minimum required by the Hong Kong Stock Exchange.
- Rationale: The rights issue comes after a previous rights issue in 2025, which was used to settle legacy liabilities, including bank and shareholder loans, and financial guarantee obligations. The current issue aims to refinance high-cost borrowing, normalise supplier payments, and support expansion.
- Financial Position:
- As at 30 September 2025: Net tangible liabilities of HK\$83.5M, cash of HK\$16.2M.
- The group reported a loss of HK\$19.4M for the half-year ended 30 September 2025.
- Major liabilities have been settled since the death of the former chairman.
- Litigation: A HK\$50M claim has been filed by World Crown Investments Limited, but management is defending the case and no material adverse change has been disclosed.
Important Shareholder Considerations and Price-Sensitive Information
- Significant Dilution Risk: Shareholders who do not subscribe will find their percentage ownership dramatically reduced. For example, if all rights are taken up by others, a shareholder’s stake could fall from 100% to 20%.
- Discounted Offer Price: The substantial discount to recent market prices may pressure existing share prices but could also attract new capital.
- Non-Underwritten Risk: The non-underwritten nature means the company may not raise the full intended amount, potentially affecting its financial recovery and operational plans.
- Major Use of Proceeds: Repayment of high-interest debt (20% p.a.) is a priority, which could materially reduce ongoing finance costs and improve the company’s financial health if successful.
- No Excess Rights Application: Investors cannot apply for more than their entitlement, limiting the ability for significant accumulation through this exercise.
- Timing and Execution Risks: If conditions are not met (e.g., approvals, minimum public float), the rights issue may not proceed, which could negatively affect the share price if anticipated funds are not raised.
- Ongoing Litigation: The pending HK\$50M claim, if lost, could impact the company’s cash position and prospects.
- Past and Future Fundraising: The company has recently completed another rights issue and does not intend further equity fundraising in the next 12 months, suggesting this is a crucial capital raise.
- Strategic Expansion: Funds will be used to expand into the Asia-Pacific market and invest in new technology, which could positively impact long-term growth if executed well.
Additional Details
- Eligibility: Only shareholders as of the record date (28 May 2026) are entitled to participate. Overseas shareholders may be excluded if local regulations make the offer impractical.
- Trading of Rights Shares: Both nil-paid and fully-paid rights shares will be traded in lots of 2,000 shares and are eligible for CCASS settlement.
- No Directors or Major Shareholders Undertaking: As of the latest practicable date, no director or substantial shareholder has committed to taking up their entitlement.
- Shareholder Structure Scenarios: If no shareholders except placees take up rights, public float could fall to 20%. In such a case, the company will scale down allocations to maintain the minimum float of 25%.
- No Material Adverse Change: The board confirms no material adverse change since 31 March 2025, other than litigation disclosed.
- Expert Confirmation: Global Link CPA Limited has provided assurance on the pro forma financials prepared for this rights issue.
Conclusion
This rights issue represents a pivotal moment for Alco Holdings Limited, offering existing shareholders a discounted opportunity to participate in the company’s refinancing and growth plans. However, it also brings dilution and execution risks, as well as the challenge of raising funds without an underwriter. Shareholders should carefully consider their options and monitor developments, especially given the pending litigation and the company’s recent financial performance.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should consult their professional advisers and review the full prospectus before making any investment decisions. The author and publisher accept no liability for investment actions taken based on this summary.
雅高控股有限公司宣布2026年大規模供股計劃：重點詳情及股東需知
日期：2026年5月29日
報告重點
- 大規模供股：雅高控股有限公司（328.HK）宣布2026年供股計劃，現有股東每持有1股可認購4股新股。
- 非包銷形式：是次供股不設包銷，未獲認購部分將以盡力基準配售予獨立第三方，集資金額不確定。
- 供股價：每股供股價為0.55港元，較最後交易日收市價（0.69港元）折讓20.3%，較過去5個交易日平均收市價（0.726港元）折讓24.2%。
- 潛在攤薄：若全數認購，將發行最多229,113,720股新股，總股本將增至286,392,150股，現有股東如不參與將大幅攤薄持股。
- 最多集資：如全數認購，最多籌得約1.26億港元（未扣除開支）。
- 用途：淨集資約1.218億港元（扣除約419萬港元開支）用途包括：
- 約41%（5,000萬港元）：償還Proyan Consultancy Limited高息借款（年息20%）。
- 約18%（2,200萬港元）：結算供應商及貿易應付款。
- 約26%（3,150萬港元）：拓展亞太市場及提升產品設計，包括設立新店及採購3D打印設備。
- 約15%（1,830萬港元）：作一般營運資金，包括人員、佣金、物流、租金、合規、IT及應急儲備。
- 重要日期：
- 除權日：2026年5月19日
- 未繳股權交易期：2026年6月2日至6月9日
- 最遲認購/付款：2026年6月12日下午4時
- 未認購股份配售：2026年6月23日至7月3日
- 新股上市：預計2026年7月13日或之前
- 不設額外認購：只能認購預分配股份，不能申請多於配額。
- 縮減機制：如全數認購會觸發全面收購或令公眾持股跌破25%，將按比例縮減分配。
- 補償安排：未認購及不合資格股東股份會配售予獨立第三方，配售溢價（扣除開支）將退還予相關股東（每人最少100港元）。
- 維持公眾持股：公司保證即使極端情況亦會維持最少25%公眾持股。
- 集資原因：2025年供股已用於清償歷史負債，現次供股主要為再融資及業務拓展。
- 財務狀況：
- 截至2025年9月30日：可見資產負債淨額為-8,345.9萬港元，現金1,620萬港元。
- 期內虧損1,940萬港元，主要負債已清償。
- 訴訟：World Crown Investments Limited正向公司索償5,000萬港元，公司正抗辯中，暫未見重大不利變化。
股東需留意及可能影響股價的重點
- 重大攤薄風險：如不參與供股，持股比例或由100%大跌至20%。
- 折讓供股：大幅折讓或影響市場股價，但亦可能吸引新資金。
- 非包銷風險：如未能全數認購，公司或未能籌足所需資金，影響財務及業務規劃。
- 主要用途：優先償還高息債務，有助減少財務費用，改善財務狀況。
- 不設額外認購：投資者不能申請多於配額，限制增持空間。
- 執行及條件風險：如未達成條件，供股可能不成，影響公司集資及股價。
- 訴訟風險：若敗訴需賠5,000萬港元，或影響流動資金。
- 近期集資：過去12個月已進行權益融資，短期內無意再融資，顯示今次為關鍵集資。
- 業務拓展：資金將用於亞太區擴展及科技投資，如執行得宜，長遠利好。
其他細節
- 資格：僅於2026年5月28日登記股東可參與，海外股東或因法規被排除。
- 股份交易：未繳及已繳供股股份以每手2,000股買賣，並可進行CCASS交收。
- 董事及主要股東暫未承諾認購：最新資料顯示，暫無董事或主要股東承諾認購其分配股份。
- 股權結構極端情況：如僅配售股份獲認購，現有公眾持股將跌至20%，屆時會縮減配售以維持25%公眾持股。
- 無重大不利變化：除已披露訴訟外，董事會確認自2025年3月31日無重大不利變化。
- 財務專家確認：Global Link CPA已就本次供股的財務資料出具專業意見。
總結
本次供股計劃對雅高控股而言屬關鍵時刻，為現有股東提供以折讓價參與公司再融資及業務發展的機會，但同時帶來攤薄及執行風險，加上高息債務及訴訟因素，股東應審慎評估自身持股及留意相關進展。
免責聲明
本文僅供資訊參考，並不構成投資建議。投資者應詳閱完整供股章程及諮詢專業顧問作出獨立判斷，作者及出版方不對任何投資行為承擔責任。
